[Skip to Navigation]
Sign In
Comment & Response
April 22, 2021

Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia—Moving From Evidence to Practice—Reply

Author Affiliations
  • 1Department of Hematology and Oncology, Massachusetts General Hospital, Boston
  • 2Duke University School of Medicine, Durham, North Carolina
JAMA Oncol. 2021;7(6):943-944. doi:10.1001/jamaoncol.2021.0709

In Reply We would like to thank Dr Bramati and colleagues for their comments regarding our randomized clinical trial.1 They highlighted the critical need to translate the science demonstrating the benefits of specialty palliative care for patients with hematologic cancers into oncology practice. We agree wholeheartedly and want to emphasize the need for further dissemination and implementation research to ensure uptake, adoption, and sustainability of palliative care integration for patients with hematologic cancers across care settings. Dissemination and implementation research will also provide us with an opportunity to study the potential barriers and facilitators for integrating palliative care for patients with hematologic cancers in diverse, real-world clinical settings.

Add or change institution